Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer

Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer

The aim of this study was to investigate whether the enumeration of circulating tumor cells (CTCs) in blood can differentiate between true localized and metastatic prostate cancer. A cross-sectional study of 104 prostate cancer patients with newly diagnosed high-risk prostate cancer was conducted. I...

Full description

Bibliographic Details
Main Authors: Wojciech A. Cieślikowski, Joanna Budna-Tukan, Monika Świerczewska, Agnieszka Ida, Michał Hrab, Agnieszka Jankowiak, Martine Mazel, Michał Nowicki, Piotr Milecki, Klaus Pantel, Catherine Alix-Panabières, Maciej Zabel, Andrzej Antczak
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Cancers
Subjects:
circulating tumor cells (ctcs)
metastases
prostate cancer
radiotherapy
early detection
Online Access:https://www.mdpi.com/2072-6694/12/1/160

Internet

https://www.mdpi.com/2072-6694/12/1/160

Similar Items